| COVID-19 pandemic in Nagaland | |
|---|---|
| Disease | COVID-19 |
| Virus strain | SARS-CoV-2 |
| Location | Nagaland |
| First outbreak | Wuhan,Hubei |
| Index case | Kohima andDimapur |
| Arrival date | 22 May 2020 |
| Government website | |
| nagahealth | |
TheCOVID-19 pandemic reached the state ofNagaland on 22 May 2020, with its first case confirmed on 25 May 2020.[1] Officially, Nagaland is the last of the northeastern states afterSikkim to report COVID-19 positive cases.
On 22 April, a 33-year-old trader based in Dimapur had tested positive inGauhati Medical College and Hospital (GMCH).
The man had been admitted to a private hospital in Dimapur for treatment but the hospital referred him to the GMCH as the State did not have testing facilities at that point of time. He tested positive hours after he was shifted in an ambulance.
On 20 July, total number of cases in Nagaland crossed 1000 mark.[5]
Total confirmed cases Active Cases Recoveries Deaths
This graph was using thelegacy Graph extension, which is no longer supported. It needs to be converted to thenew Chart extension. |
This graph was using thelegacy Graph extension, which is no longer supported. It needs to be converted to thenew Chart extension. |

Covishield
On January 1, 2021, theDrug Controller General of India, approved the emergency or conditional use ofAstraZeneca's COVID-19 vaccineAZD1222 (marketed as Covishield).[8] Covishield is developed by theUniversity of Oxford and its spin-out company,Vaccitech.[9] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf life of at least six months.
Covaxin
On January 2, 2021,BBV152 (marketed as Covaxin), first indigenous vaccine, developed byBharat Biotech in association with theIndian Council of Medical Research andNational Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[10]